Background
==========

Female gender has been reported to be an independent risk factor for coronary artery bypass grafting (CABG) in European System for Cardiac Risk Evaluation \[[@B1]\]. In comparison to male patients female patients undergoing CABG have more comorbid risk factors such as; older age, smaller body size, higher prevalance of hypertension, diabetes mellitus, unstable anjina pectoris, smaller size of coronary arteries. Numerous studies have demonstrated increased hospital mortality after CABG in female patients On the other hand studies suggest that female patients clearly benefit from CABG \[[@B2]-[@B4]\].

The effect of the body size on the CABG outcome is less clear. There is ongoing debate about obesity as a risk factor for adverse outcomes after cardiovascular procedures \[[@B5]-[@B7]\]. Some studies have documented that obesity is not a risk factor for adverse outcomes \[[@B8]-[@B10]\] whereas other studies have concluded that extreme obesity is a significant independent predictor for adverse outcomes after CABG \[[@B11],[@B12]\].

The goal of this retrospective study is to evaluate the in hospital and early postoperative outcomes in severe obese, obese and non-obese female patients after CABG.

Methods
=======

Patients
--------

In a four year period a total of 427 female patients underwent isolated CABG under cardiopulmonary bypass (CPB). Patients who underwent concomitant procedures such as; valve operation, carotid endarterectomy, were excluded.

Data collection and definitions
-------------------------------

Preoperative, intraoperative and postoperative variables and complications were collected retrospectivly from hospital database. The variables defined as follows; ***diabetes mellitus***(DM); diet-controlled, oral therapy or insulin dependent DM, ***hypertension***; history of hypertension necessitating medical treatment, ***chronic obstructive pulmonary disease;***predicting of forced expiratory volume in 1 sec or diffusion capacity less than 75% at pulmonary functional test, ***vascular disease;***peripheral, abdominal vascular pathology or operation, ***rhythm***; preoperative sinus rhythm, ***ejection fraction***≤ 40%; determined with preoperative transthoracic echocardiography and named as poor ventricular function, ***pulmonary hypertension;***pulmonary artey pressure ≥ 30 mmHg determined with preoperative transthoracic echocardiography, ***creatinin level***; blood creatinin level preoperatively and 1st postoperative day, ***thyroid disease;***hypothyroidism or hyperthyroidism necessitating therapy and all patient\'s thyroid functions were measured preoperatively, ***left main coronary artery disease***(LMCA); LMCA stenoses ≥ 70, ***preoperative myocardial infarction***(MI); history of MI before the operation, ***operative status***; elective: stabil cardiac function and operation is more than 1 day following diagnosis, urgent; the operation that occurred within 24 h of coronary catheterisation because of critically vessel lesion with unstable symptoms, emergency; operation is within the hours for evolving infarction, ischemia not responding to medical therapy, cardiogenic shock or very critically LMCA and right coronary artery disease, ***inotrophic support and/or IABP;***intraoperative and/or postoperative inotrophic - IABP support due to haemodynamic instability, ***perioperative myocardial infarction;***a new Q wave and rise in CPK-MB % ≥ 10%, ***re-exploration;***re-operation for bleeding, tamponade, ***neurological complications;***postoperative cerebrovascular accidents and/or transient ischemic attack, ***pulmonary complications;***re-entubation, pulmonary infection, severe athelectazia necessitating intensive fizyotherapy postoperatively, ***wound problems;***consist in-hospital and within 30 days following discharge; sternotomy and saphenous incision problems were seperately defined as follows; s*ternotomy wound problems*; superficial infections, deep wound-mediastinal involvement and sternal dehiscence, *saphenous incision problems*; wound healing problems requiring surgical debritman, ***mortality;***all mortality during postoperative hospital stay, ***re-hospitalization;***following discharge re-hospitalization within 30 days due to pulmonary emboli, deep venous thrombosis, plevral effusion requiring thorasentesis, heart failure, arrhytmia, severe creatinin elevation and wound problems, ***Body Mass Index (BMI);***calculated as weight (kg)/height squared (m2). The patients were allocated into three groups according to the BMI as follows;

Group 1: Severe obese patients; BMI \> 35

Group 2: Obese patients; 30 ≤ BMI ≤ 35

Group 3: Normal-slightly obese patients; BMI \< 30

Surgical technique
------------------

All patients were operated using standart CPB tecnique, aortic and two stage right atrial cannulation, systemic hypothermia (28-32 C). Internal thoracic artery and saphenous vein were harvested with conventional technique. Following cross-clamping of the aorta the heart was arrested using intermittant cold blood cardioplegia antegradely and retrogradely, continued with in every 20 min, and finally warm blood cardioplegia was administered before releasing the aortic cross-clamp. The left internal thoracic artery (LITA) was the graft of choice for left anterior descending coronary artery (LAD) in patients and saphenous vein grafts (SVG) for the other anastomosis. After distal anastomoses, proximal anastomoses were done during reperfusion with an partial aortic occluding clamp. During the CPB hematocrit levels were maintained above 20%. Also in all patients efforts were made to ensure perioperative and postoperative blood glucose levels in the range of 150 to 200 mg/dL. After routine closure of the chest, continuous suction (10 mmHg) was applied to the drains, which were milked and stripped at 30-min intervals to ensure tube patency. Chest tubes were removed the following day when the drainage was less than 20 ml/h for consecutive 4 h. All patients were extubated in the intensive care unit (ICU) after establishment of hemodynamic stability. After ICU period, regulation of blood glucose levels were done by internal medicine departmant.

Statistical analysis
--------------------

Data evaluation was carried out using a computer statistical package (SPSS 15.0 for Windows, SPSS, Inc., Chicago, IL) and are expressed as means ± SD or as frequencies or percentages. The relationships between independent preoperative and operative variables and postoperative outcome measures were investigated by One-way Anova test or χ^2^test for categorical variables. A *P*value of \<0.05 was considered significant.

Results
=======

Preoperative variables are listed in Table [1](#T1){ref-type="table"}. There were 125 patients in group 1, 122 patients in group 2 and 170 patients in group 3. The mean BMI was 37,8 ± 2,6 in group1, 32,0 ± 1,3 in group2 and 26,7 ± 2,5 in group3 respectively.

###### 

Preoperative variables

  Variable              Group 1 (n:125)   Group 2 (n:122)   Group 3 (n:170)   p-value
  --------------------- ----------------- ----------------- ----------------- -----------
  Age, (year)           63,01 ± 8,0       63,57 ± 8,4       65,6 ± 8,3        **0,015**
  BMI                   37,8 ± 2,6        32,0 ± 1,3        26,7 ± 2,5        
  DM                    54,4%             43,4%             40%               **0,043**
  Hypertension          65,6%             62,3%             57,6%             0,3
  Smoking               7,2%              11,5%             7,6%              0,4
  Cholesterol(mg/dl)    211,2 ± 47,3      209 ± 44,5        208,5 ± 50,2      0,8
  COPD                  24,8%             13,9%             21,8%             0,08
  PVD                   4%                3,3%              4,7%              0,8
  Sinus rythm           99,2%             99,1%             98,8%             0,5
  Thyroid disease                                                             
   *Hypothyroidism*     8(6,4%)           6(4,9%)           10(5,9%)          0,8
   *Hyperthyroidism*    3(2,4%)           4(3,3%)           6(3,5%)           0,8
  PreMI                 29,6%             18,2%             22,4%             0,09
  Vessel disease                                                              
    *1 vessel*          12%               9,8%              11,8%             0,98
    *2 vessel*          29,6%             30,3%             29,4%             0,98
    *3 vessel*          58,4%             59,8%             58,8%             0,98
    *LMCA*              8,8%              8,2%              6,5%              0,7
  EF%, mean ± SD        54,3 ± 10,8       55,9 ± 9,6        56,5 ± 10,3       0,17
  EF%≤ 40               16,8%             9,8%              10,6%             0,17
  PHT (mmHg,%)          16%               14,8%             20,6              0,37
  Creatinin1 (mg/dl)    0,89 ± 0,19       0,90 ± 0,15       0,87 ± 0,17       0,26
  Creatinin 2 (mg/dl)   1,1 ± 1,2         1,0 ± 0,3         0,95 ± 0,28       0,15

COPD; chronic obstructive pulmonary disease, PVD; peripheral vascular disease, PreMI; preoperative MI, PHT; pılmonary hypertension, Creatinin1; preoperatively, 2; postoperatively creatinin level

The patients in group 3 were older than the group1 and group 2 (65,6 ± 8,3 year vs 63,01 ± 8,0 and 63,57 ± 8,4 year p \< 0,05). In group 1 diabetic patients were more than in group 2 and group 3 respectively (54,4% vs 43,4% and 40%, p \< 0,05). The remaining factors of hypertension, smoking, cholesterol level, the percantage of chronic obstructive pulmonary disease (COPD), peripheral vascular disease, the percantage of sinus rythm, previous MI, left main coronary artery disease (LMCA), the extension of vessel disease, mean ejection fraction-percantage of EF % ≤ 40, pulmonary hypertension (PHT), mean preoperative and 1 st postoperative day creatinin levels showed no statistical differences between the three groups.

Operative and early postoperative variables are listed in Table [2](#T2){ref-type="table"}. Urgent operation was more in group 1 than in group 2 and 3 respectively (37,6% vs 17,2% and 21,2% p \< 0,05). Also elective surgery was more in group2 and 3 than in group 1 (75,4% and 75,9% vs 58,4% p \< 0,05). The other parameters; mean CABG number, percantage of LITA usage, mean aortic cross clamp time (ACC), cardiopulmonary bypass time (CPBT), percantage of inotrophic support, mean extubation and intensive care unit (ICU) time did not differ beetween the groups. The patients in group 3 had significantly greater postoperative drainage at 24 h compared with values in group 1 and group 2 (647 ± 142 ml vs. 539 ± 169 ml and 582 ± 133 ml, p \< 0,05). Four patients in group 3 was revised due to bleeding and/or tamponade whereas none in group 1 and 2. Also occurence of atrial fibrillation (AF), perioperative MI, neurological and pulmonary complications did not differ between the groups. The overall hospital mortality rate was 0,7%. Mortality rate in group1 was 0,8%, 0% in group2 and 1,2% in group3 respectively. Wound problem has occured in 41 patients (9,6%). The percentage of postoperative wound problems was higher in group 1 but did not show statiscially difference. Following discharge a total of 43 (10,1%) patients re-hospitalized within 30 days due to reasons mentioned above. Re-hospitalization rate was 16,1% in group1, 9,8% in group 2 and 6,5% in group 3 (p \< 0,05).

###### 

Operative and early postoperative variables

  Variable                  Group 1       Group 2       Group 3       P-value
  ------------------------- ------------- ------------- ------------- ------------
  Operative status %                                                  
    *Emergency*             5,6           6,6           3,5           0,4
    *Urgent*                37,6          17,6          21,2          **0,0001**
    *Elective*              58,4          75,8          75,9          **0,002**
  CABG (n)                  2,98 ± 0,89   2,98 ± 0,78   2,95 ± 0,79   0,93
  LITA usage%               89,6          90,2          89,7          0,3
  ACC (min)                 38,3 ± 12,0   37,8 ± 10,1   37,7 ± 10,5   0,71
  CPBT (min)                57,6 ± 16,9   56,9 ± 13,6   57,0 ± 14,6   0,82
  Inotrophic support %      20            12,3          18,9          0,21
  Extubation time(hour)     11,7 ± 3,4    11,7 ± 3,5    12,0 ± 4,4    0,62
  ICU time(hour)            25,7 ± 3,6    27,7 ± 24,3   26,7 ± 16,0   0,54
  Drenaige (ml)             539 ± 169     582 ± 133     647 ± 142     **0,0001**
  Revision                  0             0             4(2,6%)       0,053
  AF %                      24            20,5          20,0          0,68
  Perioperative MI          3(2,4%)       3(2,5%)       5(2,9%)       0,9
  NC %                      0,8           0             0,6           0,63
  Pulmonary compl.%         4,8           1,6           2,4           0,41
  Wound problems            16(12,8%)     11(9%)        14(8,2%)      0,40
   ***Sternotomy***                                                   
    *Superficial*           4(3,2%)       3(2,5%)       4(2,4%)       0,89
    *Deep*                  2(1,6%)       1(0,8%)       2(1,2%)       0,85
    *Dehisence*             4(3,2%)       3(2,5%)       3(1,8%)       0,72
   ***Saphenous***          6(4,8%)       4(3,3%)       5(2,9%)       0,67
  Mortality                 1(0,8%)       0             2(1,2%)       0,49
  Re-hospitalization        20(16,1%)     12(9,8%)      11(6,5%)      **0,02**
    *DVT*                   3             0             0             
    *DVT+PE*                1             1             0             
    *Plevral effusion*      2             1             3             
    *Heart failure*         2             1             *0*           
    *Arrythmia*             2             2             1             
    *Creatinin elevation*   2             2             1             
    *Wound problems*        *8*           5             6             

ACC; aortic cross clamp time, CPBT; cardiopulmonary bypass time, ICU; intensive care unit, AF; atrial fibrillation, NC; neurological complication, DVT; deep venos thyrombosis, PE; pulmonary emboli

Discussion
==========

Cardiovascular disease is leading cause of morbidity and mortality for women in developed and developing countries. There is considerable evidence that female gender carry a higher CABG mortality when compared with the male patients \[[@B13]-[@B15]\]. On the other hand obesity is considered to be a major risk factor in patients undergoing CABG. With the increasing of BMI also comorbidty increases \[[@B16],[@B17]\]. There are major differences in the risk profile of female patients compared with the profile of male patients \[[@B18],[@B19]\]. The great majority of studies show that diabetes is 40% to 50% more common in female patients than male patients undergoing CABG \[[@B20],[@B21]\]. In this study diabetes is found to be 45,3% in totally whereas 54,4% in severe obese patients. It is well-known that there is a clear association of diabetes with adverse postoperative outcome in surgical patients. Despite the usage of prophylactic antibiotics, sternal wound infections are associated high mortality and morbidity. In our severe obese patients sternal superficial infections and sternal dehisence were more common but not statistically significant than the other groups. Some studies were emphasised that hyperglycemia in the first 2 postoperative days is the single most important predictor of mediastinitis after cardiac surgery and blood glucose level must be maintained below 200 mg/dL \[[@B22],[@B23]\]. As mentioned before in our patients special efforts were made to ensure perioperative and postoperative blood glucose levels in the range of 150 to 200 mg/dL with the using of continuous intravenous insulin infusions.

Hypothyroidism is associated with impaired ventricular contractility and in female patients there is a higher incidence of hypothyroidism undergoing CABG \[[@B24]\]. In the study of Zindrou and colleagues they found a high mortality rate (16,7%) in female patients requiring thyroid replacement therapy whereas not in male patients \[[@B25]\]. In our clinic all patient\'s thyroid functions were measured preoperatively and hypothyroidic patients were maintained in a euthyroid state before the operation. In non-elective status patients therapy was begun before the operation and contiuned following operation.

The use of at least one LITA confers both in-hospital and long-term improvement in CABG mortality \[[@B26],[@B27]\]. However usage of LITA as a conduit in female patients is only 60%-75% of cases \[[@B28],[@B29]\]. This is significantly less than LITA usage in male patients. Actually there is no objective reason to use the LITA less ferquently in females than the males. Perhaps the presence of a soft friable sternum that predisposes sternal dehisence is a valid reason to avoid use of LITA \[[@B30]\]. In the study of Aldea and colleagues LITA was used in 91% of female patients and found no gender differences in operative mortality \[[@B31]\].

In most series there is a higher rate of non-elective CABG in female patients \[[@B28],[@B31]\]. Likewise in our study the rate of non-elective surgery was 29,2% in all patients whereas statiscially higher in group 1 than the other groups. Also in other studies it was emphasised that use of LITA is safe when urgent and emergency operations are being performed \[[@B32],[@B33]\]. In our study use of LITA as a conduit was found 89,6% in severe obese group even percentage of urgent surgery was high.

Some studies found a significant reduction for the risk of postoperative bleeding in obese patients \[[@B34],[@B35]\]. Likewise in our study the amount of bleeding and re-exploration rate was less in obese grups than the non-obese grup.

Atrial fibrillation (AF) is a frequent event after CABG with an incidence of 15-40%. It may result in hemodynamic compromise during the postoperative period. There are some reports saying AF are seen in high BMI score patients \[[@B36],[@B37]\]. In our patients there was no significant difference between the three groups

We did not find a significant difference ICU time, creatinin levels, neurological complications and mortality rates between the three groups.

Obesity alters the pulmonary function leading to an increase in functional residual capacity, and a decrease in vital capacity and maximum voluntary ventilation \[[@B38]\]. In addition, anaesthetic drugs that are revealed from the fat tissue may prolong the entubation time. Also patients with low BMI have remarkable haemodilution, fall in the oncotic pressure during CPB and this may lead excess fluid extravasation \[[@B39]\]. In this study we did not find a significant difference for extubation time between the groups. Hovewer postoperatively pulmonary complication was more common in group1 but showed no statiscially difference.

Readmission following discharge is an important adverse outcome of CABG surgery. Hannan El et al. examined the frequency and causes of CABG surgery readmissions and in their study they found 15,3% readmisions within 30 days following discharge. Also they found female gender is a risk factor of readmission after CABG \[[@B40]\]. In our study a total of 43 (10,1%, mostly in group1) patients readmitted and re-hospitalized following discharge.

Limitations of the study
========================

This study was done on a retrospective series from a single institution and also gives only in-hospital and early postoperative period outcomes. Further complementary studies with higher number of patients and including early, mid-term, long-term results in contemporary methods are warranted.

Conclusion
==========

This study may give an aspect for evaluations of the inhospital-early mortality and morbidity after CABG in female patients in different BMI. Female gender and also severe obesity is not a risk factor in-hospital mortality. However, severe obese female patients appear to have more wound problems and re-hospitalization rate after CABG compared to obese and non-obese patients.
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